Paper40429486
Insights on the Pathogenesis of Mycobacterium abscessus Infection in Patients with Cystic Fibrosis.
Basher M and 2 others. J Clin Med, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Insights on the Pathogenesis of Mycobacterium abscessus Infection in Patients with Cystic Fibrosis. Papers, record 40429486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40429486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Insights on the Pathogenesis of Mycobacterium abscessus Infection in Patients with Cystic Fibrosis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References126
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26861246 | Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study. | Infection | 2016 | https://conductscience.org/library/papers/26861246 | PubMed |
| 2 | 36637124 | A Rough Colony Morphology of Mycobacterium abscessus Is Associated With Cavitary Pulmonary Disease and Poor Clinical Outcome. | J Infect Dis | 2023 | https://conductscience.org/library/papers/36637124 | PubMed |
| 3 | 29632012 | High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29632012 | PubMed |
| 4 | 25052484 | Mechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis. | J Antibiot (Tokyo) | 2014 | https://conductscience.org/library/papers/25052484 | PubMed |
| 5 | 10984324 | Mechanisms of action and resistance of older and newer fluoroquinolones. | Clin Infect Dis | 2000 | https://conductscience.org/library/papers/10984324 | PubMed |
| 6 | 22403802 | Immune responses in cystic fibrosis: are they intrinsically defective? | Am J Respir Cell Mol Biol | 2012 | https://conductscience.org/library/papers/22403802 | PubMed |
| 7 | 37200238 | The cell envelope of Mycobacterium abscessus and its role in pathogenesis. | PLoS Pathog | 2023 | https://conductscience.org/library/papers/37200238 | PubMed |
| 8 | 26890211 | Treatment of Mycobacterium abscessus Infection. | Emerg Infect Dis | 2016 | https://conductscience.org/library/papers/26890211 | PubMed |
| 9 | 20440275 | How antibiotics kill bacteria: from targets to networks. | Nat Rev Microbiol | 2010 | https://conductscience.org/library/papers/20440275 | PubMed |
| 10 | 32531843 | Myeloid CFTR loss-of-function causes persistent neutrophilic inflammation in cystic fibrosis. | J Leukoc Biol | 2020 | https://conductscience.org/library/papers/32531843 | PubMed |
| 11 | 27637463 | Mycobacterium abscessus ESX-3 plays an important role in host inflammatory and pathological responses during infection. | Microbes Infect | 2017 | https://conductscience.org/library/papers/27637463 | PubMed |
| 12 | 15013035 | Oxazolidinones: activity, mode of action, and mechanism of resistance. | Int J Antimicrob Agents | 2004 | https://conductscience.org/library/papers/15013035 | PubMed |
| 13 | 31010859 | Mycobacterium abscessus Cells Have Altered Antibiotic Tolerance and Surface Glycolipids in Artificial Cystic Fibrosis Sputum Medium. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31010859 | PubMed |
| 14 | 26335953 | Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection. | Pediatr Pulmonol | 2015 | https://conductscience.org/library/papers/26335953 | PubMed |
| 15 | 35732550 | Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease. | J Cyst Fibros | 2022 | https://conductscience.org/library/papers/35732550 | PubMed |
| 16 | 38541936 | The Impact of Antimicrobial Resistance in Cystic Fibrosis. | J Clin Med | 2024 | https://conductscience.org/library/papers/38541936 | PubMed |
| 17 | 22290346 | Mycobacterium abscessus: a new antibiotic nightmare. | J Antimicrob Chemother | 2012 | https://conductscience.org/library/papers/22290346 | PubMed |
| 18 | 16735722 | Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. | Microbiology (Reading) | 2006 | https://conductscience.org/library/papers/16735722 | PubMed |
| 19 | 37239050 | Understanding the Phage-Host Interaction Mechanism toward Improving the Efficacy of Current Antibiotics in Mycobacterium abscessus. | Biomedicines | 2023 | https://conductscience.org/library/papers/37239050 | PubMed |
| 20 | 32194537 | Extreme Drug Tolerance of Mycobacterium abscessus "Persisters". | Front Microbiol | 2020 | https://conductscience.org/library/papers/32194537 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42403389 | Host susceptibility spectrum and diagnostic challenges in pediatric nontuberculous mycobacterial disease: a case series of five patients with literature review. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42403389 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40429486
GET https://conductscience.org/api/papers/v1/40429486/references?page=2